CVD prevalence in Indonesia spikes the beat<br> of cardiac rhythm management market

Source：Frost& Sullivan Release Date：2012-06-25 385

Medical Equipment

Indonesia has a high prevalence of both communicable and non-communicable diseases. Amongst non-communicable diseases, cardiovascular disease's incidence is 7.2% of the total population of 247 million. Of these, 2.1 million suffer from disorders caused by the rhythm of heart, signifying vast opportunities for the CRM market on a small base.

The occurrence of cardiovascular diseases is on the rise due to sedentary lifestyles, unhealthy eating habits and urbanization. However, changes in healthcare services legislation, revamp in health insurance policies, an aging population, affluent and dormant life style, smoking and the urge to be treated will boost the Indonesian CRM market.

Pacemakers account for 49.6% of the unit shipment, whilst cardiac ablation runs close with 42.2%, according to a Frost & Sullivan research service.

Titled “Indonesian Market for Cardiac Rhythm Management”, it provides real-time, on-the-ground market intelligence on the dynamics of cardiac rhythm management (CRM)-implantable devices and market trends in Indonesia. It forecasts market volumes and revenues and analyses market and technology trends, industry challenges, market drivers and restraints and offers competitive analysis. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: pacemakers (single chamber and dual chamber), implantable cardioverter-defibrillators (ICD) (single chamber and dual chamber), cardiac resynchronization therapy (CRT) (pacemakers and defibrillators) and cardiac ablation.

Nike Mens Shoes